Natriuretic peptides as markers of preclinical cardiac disease in obesity.
about
A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.The heart in obesity-hypertension.Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation.Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status.Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.
P2860
Q35189862-06E60A8F-B8FC-4A74-9C3B-528E61700D7EQ36216822-0764264F-E61D-4F05-8E4F-56D846F5706AQ36458845-90B043FF-8020-4F5C-8288-4FD1C07E34B8Q37092258-79541163-FB0B-4CA2-8AED-C98073BAA210Q37138416-D5E0195D-BDA0-4AA3-AE6B-B1A6DD471D40Q47639263-6D515F1D-CDD7-4ACB-8D47-B76A9C7AB573Q48288289-F1DB7EAC-5A0F-42EC-96B9-88EB2F2B63EBQ48942319-03CE3EAD-DD32-4CA2-9B4C-1262E86D1A7CQ50122007-E4165D42-0462-4E2E-B914-5450BD732819
P2860
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@en
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@nl
type
label
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@en
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@nl
prefLabel
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@en
Natriuretic peptides as markers of preclinical cardiac disease in obesity.
@nl
P2093
P2860
P1476
Natriuretic peptides as markers of preclinical cardiac disease in obesity
@en
P2093
Giovanella L
Imperiale D
Piantanida E
P2860
P304
P356
10.1111/J.1365-2362.2004.01348.X
P577
2004-05-01T00:00:00Z